Mersana Therapeutics, Inc. (MRSN)

Jan 6, 2026 - MRSN was delisted (reason: acquired by DAWN)

29.08

+0.04 (0.14%)

Inactive · Last trade price on Jan 5, 2026

Mersana Therapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	33.18	40.5	36.86	26.58	0.04	0.83
Revenue Growth	-4.76%	9.88%	38.65%	61716.28%	-94.81%	-98.03%
Gross Profit	33.18	40.5	36.86	26.58	0.04	0.83
Operating Income	-67.38	-73.34	-179.67	-203.77	-168.86	-88.11
Net Income	-70.08	-69.19	-171.67	-204.21	-170.06	-88.05
Earnings Per Share	-13.88	-14.00	-37.00	-54.50	-60.25	-35.75
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Investments	56.39	134.62	209.08	280.71	177.95	255.09
Total Debt	2.29	28.6	33.63	36.3	38.18	16.57
Net Cash (Debt)	54.1	106.02	175.45	244.41	139.77	238.52
Net Cash Growth	-56.26%	-39.57%	-28.21%	74.87%	-41.40%	159.19%
Net Cash Per Share	10.87	21.63	37.78	65.24	49.51	96.98

Cash Flow & CapEx

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Cash Flow	-74.37	-82.34	-168.88	-49.36	-139.99	-74.7
Capital Expenditures	-	-0.13	-2.17	-2.2	-0.65	-0.47
Free Cash Flow	-74.37	-82.47	-171.05	-51.56	-140.64	-75.17
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-203.06%	-181.09%	-487.51%	-766.59%	-392693.02%	-10641.30%
Pretax Margin	-198.76%	-169.82%	-465.80%	-768.26%	-395488.37%	-10633.45%
Profit Margin	-211.21%	-170.86%	-465.80%	-768.26%	-395488.37%	-10633.45%
FCF Margin	-224.14%	-203.65%	-464.12%	-193.97%	-327060.47%	-9078.38%

Valuation

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul '26 Jul 27, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
PS Ratio	4.36	4.36	7.60	23.18	10662.10	2212.40